Capital Impact Advisors, LLC Bridge Bio Pharma, Inc. Transaction History

Capital Impact Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	SELL	$23.0 - $31.04 $19,251 - $25,980	-837 Reduced 5.67%	13,925 $352,000
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $178,075 - $263,369	-6,511 Reduced 30.61%	14,762 $456,000
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $107,977 - $223,818	-6,393 Reduced 23.11%	21,273 $560,000
Q1 2023 May 23, 2023	SELL	$7.17 - $18.55 $35,871 - $92,805	-5,003 Reduced 15.31%	27,666 $458,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $18,272 - $31,230	-2,711 Reduced 7.66%	32,669 $248,000
Q3 2022 Nov 21, 2022	BUY	$7.94 - $12.36 $42,645 - $66,385	5,371 Added 17.9%	35,380 $341,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $156,346 - $364,309	30,009 New	30,009 $272,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.